Neogen acquires pet medications maker CAPInnoVet

Original Source LANSING — Food and animal safety products maker Neogen Corp. has bolstered its holding in the fast-growing veterinary market with the acquisition of an Atlanta-based companion animal health company. On Monday, Lansing-based Neogen (Nasdaq: NEOG) said it acquired CAPInnoVet Inc., a provider of pet medications that offer protection from fleas, ticks and mosquitoes at what…

Read More

Phenomics Health Validates Patented Technology Following Seed Financing Personalized Medicine for Medication Selection and Monitoring

Plymouth, MI – September 22, 2021 – Phenomics Health Inc., a platform bioinformatics-based precision medicine company, today announced completion of clinical product development and validation for its PrecīsMed™ pharmacometabolomics (PMx) technology in its new CLIA laboratory located at the Michigan Life Science and Innovation Center. The company’s laboratory operations, validation, as well as ongoing research…

Read More

Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration

ANN ARBOR, MI, September 16, 2021 — The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone. The…

Read More

Cayman Offers Multidisciplinary Lipid-Based Drug Delivery Capabilities

ANN ARBOR, MI, September 14, 2021 — Cayman Chemical, leader in the synthesis, purification, and characterization of lipids, has partnered with NanoImaging Services and T&T Scientific to provide a multi-pronged platform that synthesizes, characterizes, and formulates lipid-based nanoparticles to help researchers and pharmaceutical companies alike develop vaccines and other novel therapeutics from the preclinical stage…

Read More

FDA Approves First COVID-19 Vaccine

Original Source Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency…

Read More

FDA Targets Early September for Approving Pfizer’s Covid-19 Vaccine

Original Source The Food and Drug Administration is expected to approve Pfizer’s coronavirus vaccine by early September, amid a resurgence of cases that has heightened pressure on the administration to get more Americans vaccinated. While the agency had long eyed the fall for granting full licensure, officials have recently accelerated their work, and now hope…

Read More

WHO Issues New Recommendations on Human Genome Editing for the Advancement of Public Health

Original Source Two new companion reports released today by the World Health Organization (WHO) provide the first global recommendations to help establish human genome editing as a tool for public health, with an emphasis on safety, effectiveness and ethics. The forward-looking new reports result from the first broad, global consultation looking at somatic, germline and heritable human…

Read More

Sickle Cell Disease and a Pivotal Moment to End Health Inequality

Original Source Covid-19 laid bare the long-standing vulnerability of minority and low-income communities in U.S. society and its health system even as we celebrated the power of scientific innovation to rein in the pandemic. It’s time to turn that innovation, driven by an even greater mind shift, to end inequality in treatment. In perhaps no…

Read More

New Study Shows Partnership Between Michigan’s Skilled Craft Unions And The Biopharmaceutical Industry Resulted In More Than $1.1 Billion In Investment Over Six Years

Investment Yielded Nearly $26 Million in Earnings for Michigan’s Skilled Craft Union Workers By PILMA KALAMAZOO, Mich., July 1, 2021 /PRNewswire/ — The Pharmaceutical Industry Labor-Management Association today released an update to its first-of-its-kind report on the economic impact of the long-standing partnership between skilled craft unions and the biopharmaceutical industry in Michigan and 13 other states. The report…

Read More

BIO – Why we Must Improve Clinical Trial Diversity – and How

By J.P Carroll – View Original Publication Black Americans have lost 3.25 years of life expectancy and Hispanic Americans have lost 3.88 years as a result of the COVID-19 pandemic, according to new research published by the British Medical Journal. This is just the latest among the longstanding health inequities brought to light by the pandemic, which has…

Read More